Lennon David James's Form 4 filing
Whitehawk Therapeutics, Inc. (WHWK) · filed Apr 8, 2026
- Accession no.
- 0001995275-26-000008
- Filed
- Apr 8, 2026
- Trade date
- Apr 6-8, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $899.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lennon David JamesCIK 0001995275 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Common Stock | SSaleDisposed | −102,395 | $3.51 | −$359,406.45 | 691,154 | Direct | |
| Apr 7, 2026 | Common Stock | SSaleDisposed | −94,087 | $3.43 | −$322,718.41 | 597,067 | Direct | |
| Apr 8, 2026 | Common Stock | SSaleDisposed | −63,945 | $3.40 | −$217,413 | 533,122 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.